NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 324 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94 | -3.1% | 13 | 0.0% | 0.00% | – |
| Q2 2023 | $97 | +7.8% | 13 | 0.0% | 0.00% | – |
| Q1 2023 | $90 | -32.8% | 13 | 0.0% | 0.00% | – |
| Q4 2022 | $134 | – | 13 | -27.8% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 18 | -70.0% | 0.00% | -100.0% |
| Q2 2022 | $3,000 | +200.0% | 60 | +328.6% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 14 | +133.3% | 0.00% | – |
| Q4 2021 | $1,000 | -66.7% | 6 | -57.1% | 0.00% | -100.0% |
| Q3 2021 | $3,000 | +50.0% | 14 | +40.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -94.1% | 10 | -96.7% | 0.00% | -100.0% |
| Q4 2020 | $34,000 | +112.5% | 300 | +100.0% | 0.00% | 0.0% |
| Q3 2020 | $16,000 | -5.9% | 150 | -27.2% | 0.00% | -20.0% |
| Q2 2020 | $17,000 | – | 206 | +312.0% | 0.01% | – |
| Q3 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |